Notably, these BTIC type-unique SMAD3 binding events are associated with TGF-β-dependent genes in the corresponding model (MDA-unique genes with MDA-unique SMAD3 binding, and HCC-unique genes with HCC-unique SMAD3 binding) 24 hr after pathway activation. Here, SMAD3 is linked to hepatocellular carcinoma.